Aberrant BMP2 Signaling in Patients Diagnosed with Osteoporosis

Aberrant BMP2 Signaling in Patients Diagnosed with Osteoporosis

The most common bone disease in humans is osteoporosis (OP). Current therapeutics targeting OP have several negative side effects. Bone morphogenetic protein 2 (BMP2) is a potent growth factor that is known to activate both osteoblasts and osteoclasts. It completes these actions through both SMAD-de...

Full description

Bibliographic Details
Main Authors:	Hilary W. Durbano, Daniel Halloran, John Nguyen, Victoria Stone, Sean McTague, Mark Eskander, Anja Nohe
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	International Journal of Molecular Sciences
Subjects:	osteoporosis BMP2 CK2.3 BMPRIa CK2
Online Access:	https://www.mdpi.com/1422-0067/21/18/6909

Similar Items

Bone Morphogenetic Protein-2 in Development and Bone Homeostasis
by: Daniel Halloran, et al.
Published: (2020-09-01)

A Synthetic Peptide, CK2.3, Inhibits RANKL-Induced Osteoclastogenesis through BMPRIa and ERK Signaling Pathway
by: John Nguyen, et al.
Published: (2020-07-01)

Age-Related Low Bone Mineral Density in C57BL/6 Mice Is Reflective of Aberrant Bone Morphogenetic Protein-2 Signaling Observed in Human Patients Diagnosed with Osteoporosis
by: Daniel Halloran, et al.
Published: (2022-09-01)

A Novel Peptide, CK2.3, Improved Bone Formation in Ovariectomized Sprague Dawley Rats
by: Linda Sequeira, et al.
Published: (2020-07-01)

The Role of BMP Signaling in Osteoclast Regulation
by: Brian Heubel, et al.
Published: (2021-06-01)

Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma
by: Anne S. Boewe, et al.
Published: (2022-04-01)

Study of gastrointestinal neoplasms, histopathologic and immunohistochemical correlation using HER-2/NEU, CK-7 and CK-20
by: Pramod Kumar Reddy M, et al.
Published: (2023-07-01)

Synthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1<i>H</i>-benzimidazol-1-yl)propan-1-ols—Intracellular TBBi-Based CK2 Inhibitors with Proapoptotic Properties
by: Konrad Chojnacki, et al.
Published: (2021-06-01)

Bone Morphogenetic Protein-2 Conjugated to Quantum Dot<sup>®</sup>s is Biologically Functional
by: Daniel Halloran, et al.
Published: (2020-06-01)

SGC-CK2-1 Is an Efficient Inducer of Insulin Production and Secretion in Pancreatic β-Cells
by: Mandy Pack, et al.
Published: (2021-12-01)

Role of Protein Kinase CK2 in Aberrant Lipid Metabolism in Cancer
by: Barbara Guerra, et al.
Published: (2020-10-01)

Cancer Stem Cell and Aggressiveness Traits Are Promoted by Stable Endothelin-Converting Enzyme-1c in Glioblastoma Cells
by: Ignacio Niechi, et al.
Published: (2023-02-01)

Protein Kinase CK2α’, More than a Backup of CK2α
by: Mathias Montenarh, et al.
Published: (2023-12-01)

Formulation and Investigation of CK2 Inhibitor-Loaded Alginate Microbeads with Different Excipients
by: Boglárka Papp, et al.
Published: (2023-11-01)

The Immune Regulatory Role of Protein Kinase CK2 and Its Implications for Treatment of Cancer
by: Huixian Hong, et al.
Published: (2021-12-01)

Anti-CK7/CK20 Immunohistochemistry Did Not Associate with the Metastatic Site in TTF-1-Negative Lung Cancer
by: Alice Court, et al.
Published: (2022-06-01)

Contribution of the CK2 Catalytic Isoforms α and α’ to the Glycolytic Phenotype of Tumor Cells
by: Francesca Zonta, et al.
Published: (2021-01-01)

CK2 and the Hallmarks of Cancer
by: May-Britt Firnau, et al.
Published: (2022-08-01)

RETRACTED: Cytokinin and abiotic stress tolerance -What has been accomplished and the way forward?
by: Sayanti Mandal, et al.
Published: (2022-08-01)

RETRACTED: Corrigendum: Cytokinin and abiotic stress tolerance ‐What has been accomplished and the way forward?
by: Sayanti Mandal, et al.
Published: (2024-01-01)

Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress
by: Lingli Ding, et al.
Published: (2023-11-01)

Dysferlinopathy: A Case Report and Literature Update
by: Orkide Kutlu, et al.
Published: (2016-12-01)

CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model
by: George V. Pérez, et al.
Published: (2022-12-01)

Clinicopathological Evaluation of Gall-Bladder Lesions in Cholecystectomy Specimens with Special Emphasis to Incidentally Detected Cases of Gall-Bladder Carcinoma Along with Immunohistochemical Study of Cytokeratin 7 and Cytokeratin 20
by: Kakoli Bora, et al.
Published: (2023-08-01)

Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma
by: Ketuan Huang, et al.
Published: (2024-02-01)

Evaluation of creatine kinase (CK)-MB to total CK ratio as a diagnostic biomarker for primary tumors and metastasis screening
by: Yan Li, et al.
Published: (2023-11-01)

Can Blood Biomarkers Be Used to Assess Oxidative Stress in COPD Patients After Pulmonary Rehabilitation
by: Beykumül A, et al.
Published: (2023-10-01)

Biochemical Targets and Molecular Mechanism of Ginsenoside Compound K in Treating Osteoporosis Based on Network Pharmacology
by: Sen Zhang, et al.
Published: (2022-11-01)

Protein Kinase CK2 Regulates Nerve/Glial Antigen (NG)2-Mediated Angiogenic Activity of Human Pericytes
by: Beate M. Schmitt, et al.
Published: (2020-06-01)

Diagnostic value of the creatine kinase-MB/creatine kinase and neutrophil/lymphocyte ratios in acute myocardial infarction
by: Yin Liu, et al.
Published: (2024-04-01)

Expression of (TTF-1), CK-7 and CK-20 Immunohistochemical Marker in Neoplastic and Non-neoplastic Endometrium.
by: Sazan A. AL-Atrooshi, et al.
Published: (2015-01-01)

Asemptomatik kreatin kinaz (CK) yüksekliği: Hiper-CK-emi
by: Oğuz Abdullah Uyaroğlu
Published: (2020-06-01)

Zebrafish as model system for the biological characterization of CK1 inhibitors
by: Laura Meier, et al.
Published: (2023-09-01)

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
by: Zaira Spinello, et al.
Published: (2021-04-01)

Nuclear Transport of Respiratory Syncytial Virus Matrix Protein Is Regulated by Dual Phosphorylation Sites
by: Reena Ghildyal, et al.
Published: (2022-07-01)

Increased Creatine Kinase May Predict A Worse COVID-19 Outcome
by: Daniele Orsucci, et al.
Published: (2021-04-01)

Natural Compounds Isolated from <i>Stachybotrys chartarum</i> Are Potent Inhibitors of Human Protein Kinase CK2
by: Samer Haidar, et al.
Published: (2021-07-01)

Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms
by: Emanuela B. Pucko, et al.
Published: (2022-01-01)

An Iron Shield to Protect Epigallocatehin-3-Gallate from Degradation: Multifunctional Self-Assembled Iron Oxide Nanocarrier Enhances Protein Kinase CK2 Intracellular Targeting and Inhibition
by: Luca Fasolato, et al.
Published: (2021-08-01)

Characterization of RAGE and CK2 Expressions in Human Fetal Membranes
by: Karen Coste, et al.
Published: (2023-02-01)